ArsenalBio raises $325M in one of the year’s largest biotech funding rounds

Arsenal Biosciences on Wednesday said it has raised $325 million in one of the largest private funding rounds for a biotechnology startup this year, bucking a slump in venture investment into cell and gene therapy developers.